These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29306515)

  • 21. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins.
    Connolly JA; Shinohara K; Presti JC; Carroll PR
    Urology; 1996 Feb; 47(2):225-31. PubMed ID: 8607239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer.
    Alfarone A; Panebianco V; Schillaci O; Salciccia S; Cattarino S; Mariotti G; Gentilucci A; Von Heland M; Passariello R; Gentile V; Sciarra A
    Crit Rev Oncol Hematol; 2012 Oct; 84(1):109-21. PubMed ID: 22401991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
    Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
    Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
    Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
    J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
    Yoo S; Kim JK; Jeong IG
    Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.
    Jeong IG; Lim JH; You D; Kim MH; Choi HJ; Kim JK; Cho KS; Hong JH; Ahn H; Kim CS
    J Urol; 2013 Dec; 190(6):2054-60. PubMed ID: 23791890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy.
    Manzone TA; Malkowicz SB; Tomaszewski JE; Schnall MD; Langlotz CP
    Radiology; 1998 Nov; 209(2):537-42. PubMed ID: 9807586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and management of prostate-specific antigen recurrence after radical prostatectomy for localized prostate cancer.
    Naito S
    Jpn J Clin Oncol; 2005 Jul; 35(7):365-74. PubMed ID: 15976063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
    Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
    J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Importance of transrectal ultrasonography in the detection of local recurrence of prostatic carcinoma after radical prostatectomy].
    L'upták J; Kliment J; Svihra J; Eliás B
    Rozhl Chir; 2001 Feb; 80(2):90-4. PubMed ID: 12881924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
    Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Partin AW
    J Urol; 2006 Oct; 176(4 Pt 1):1404-8. PubMed ID: 16952644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?
    Toussi A; Stewart-Merrill SB; Boorjian SA; Psutka SP; Thompson RH; Frank I; Tollefson MK; Gettman MT; Carlson RE; Rangel LJ; Karnes RJ
    J Urol; 2016 Jun; 195(6):1754-9. PubMed ID: 26721226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very late prostate cancer local recurrence 23 years after radical prostatectomy.
    Liedberg F; Olsson H; Sundqvist P
    Scand J Urol Nephrol; 2012 Aug; 46(4):304-5. PubMed ID: 22375585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
    Fuchsjäger MH; Shukla-Dave A; Hricak H; Wang L; Touijer K; Donohue JF; Eastham JA; Kattan MW
    BJU Int; 2009 Aug; 104(3):315-20. PubMed ID: 19220263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.